|
Volumn 33, Issue 2, 1998, Pages 25-38
|
New directions in asthma drug therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTIASTHMATIC AGENT;
BETA1 INTEGRIN;
CORTICOSTEROID;
CYTOKINE;
HISTAMINE;
IMMUNOGLOBULIN E;
INTERLEUKIN 4;
INTERLEUKIN 5;
LEUKOTRIENE;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
LIPOXYGENASE INHIBITOR;
PRANLUKAST;
THROMBOCYTE ACTIVATING FACTOR;
THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;
VACCINE;
ZAFIRLUKAST;
ZILEUTON;
ALLERGIC ASTHMA;
ASTHMA;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
INFLAMMATION;
REVIEW;
|
EID: 0032519482
PISSN: 87502836
EISSN: None
Source Type: Journal
DOI: 10.1080/21548331.1998.11443632 Document Type: Review |
Times cited : (2)
|
References (11)
|